Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 342 | 458 | 396 | 814 | -216 |
| Cost of Goods | N/A | N/A | N/A | 12 | 101 |
| Gross Profit | 342 | 458 | 396 | 802 | -317 |
| Operating Expenses | 8,546 | 7,678 | 7,096 | 8,875 | 7,455 |
| Operating Income | -8,204 | -7,220 | -6,700 | -8,061 | -7,671 |
| Other Income | -110 | 117 | 255 | 291 | 531 |
| Pre-tax Income | -8,314 | -7,103 | -6,445 | -7,770 | -7,140 |
| Net Income Continuous | -8,314 | -7,103 | -6,445 | -7,770 | -7,140 |
| Net Income Discontinuous | -1,058 | -652 | -2,772 | -1,196 | -1,054 |
| Net Income | $-9,372 | $-7,755 | $-9,217 | $-8,966 | $-8,194 |
| EPS Basic Total Ops | -3.00 | -2.60 | -3.00 | -3.00 | -2.60 |
| EPS Basic Continuous Ops | -2.80 | -2.40 | -2.20 | -2.60 | -2.40 |
| EPS Basic Discontinuous Ops | -0.40 | -0.20 | -0.80 | -0.40 | -0.40 |
| EPS Diluted Total Ops | -3.00 | -2.60 | -3.00 | -3.00 | -2.60 |
| EPS Diluted Continuous Ops | -2.80 | -2.40 | -2.20 | -2.60 | -2.40 |
| EPS Diluted Discontinuous Ops | -0.40 | -0.20 | -0.80 | -0.40 | -0.40 |
| EBITDA(a) | $-7,858 | $-6,991 | $-6,711 | $-8,227 | $-8,070 |